Serina Therapeutics (SER) Assets (2017 - 2026)

Serina Therapeutics has disclosed Assets across 10 years of filings, most recently posting $25.8 million for Q2 2026.

• In Q2 2026, Assets rose 188.71% year-over-year to $25.8 million; the TTM figure through Jun 2026 stood at $25.8 million (up 188.71% YoY), while the FY2025 annual figure was $7.0 million, up 3.38% from the prior year.
• Assets came in at $25.8 million for Q2 2026 at Serina Therapeutics, up from $7.0 million in the prior quarter.
• In the past five years, Assets ranged from a high of $25.8 million in Q2 2026 to a low of $497000.0 in Q1 2023.
• Average Assets over 5 years is $7.6 million, with a median of $7.0 million recorded in 2025.
• Year-over-year, Assets slumped 81.7% in 2023 and jumped 2084.31% in 2024.
• Over 5 years, Assets stood at $3.2 million in 2022, then surged by 176.7% to $9.0 million in 2023, then retreated by 25.02% to $6.7 million in 2024, then climbed by 3.38% to $7.0 million in 2025, then jumped by 271.37% to $25.8 million in 2026.
• Per Business Quant data, the three most recent Assets figures were $25.8 million in Q2 2026, $7.0 million in Q4 2025, and $12.4 million in Q3 2025.